Cough and Hemorrhoids
Is Cough a Predisposing Factor for Hemorrhoids? A Prospective, Analytical Study
1 other identifier
observational
134
1 country
1
Brief Summary
The aim of the study is to investigate the relationship between hemorrhoids and cough by assessing the symptoms, duration, and severity of cough in patients who will present to the general surgery outpatient clinic of Muğla Education and Research Hospital (MERH) with symptoms such as bleeding, pain, itching, fecal leakage, prolapse, and mucus discharge. These patients will be diagnosed with hemorrhoidal disease through rectal examination to detect anal pathology and will be graded according to mucosal prolapse. Our study will aim to determine whether cough is a predisposing factor for hemorrhoids by evaluating the presence, duration, and frequency of cough symptoms in patients with hemorrhoids. The study will be designed as a cross-sectional, analytical, and descriptive study. Between March 2025 and June 2025, patients with newly diagnosed hemorrhoids who will present to the MEAH General Surgery Outpatient Clinic will undergo physical examinations and will be assessed for cough symptoms. Evaluations will include height and weight measurements, the Leicester Cough Questionnaire, the Cough Visual Analog Scale (VAS) questionnaire, duration of cough (categorized as acute if shorter than 4 weeks, or chronic if longer than 4 weeks), timing of cough (day, night, or all day), comorbidities (such as COPD, asthma, chronic bronchitis, interstitial lung disease, idiopathic pulmonary fibrosis, and others), and smoking history (active, former, or never smoked). The primary endpoint will be to compare the relationship between the severity of hemorrhoids and the duration and frequency of cough in patients with both conditions. The secondary endpoint will be to compare the grade of hemorrhoids with comorbid chest diseases in these patients. The tertiary endpoint will be to compare the degree of hemorrhoids with the smoking history of patients who have both hemorrhoids and cough.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2025
CompletedFirst Posted
Study publicly available on registry
March 14, 2025
CompletedStudy Start
First participant enrolled
March 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 14, 2025
CompletedMay 11, 2025
March 1, 2025
6 months
March 10, 2025
May 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Leicester cough questionnaire
The primary endpoint is to compare the relationship between the severity of hemorrhoids and the duration and frequency of cough in patients with hemorrhoids and cough.
day 1
Secondary Outcomes (1)
Comobidities
day 1
Other Outcomes (1)
Smoking
day 1
Study Arms (1)
coughing hemorrhoids
Patients diagnosed with hemorrhoidal disease in the general surgery outpatient clinic of our hospital
Eligibility Criteria
Patients diagnosed with hemorrhoidal disease in MERH General Surgery Outpatient Clinic who meet the inclusion criteria
You may qualify if:
- Being 18 years of age or older
- Speaking and understanding Turkish
- To be mentally and cognitively capable of understanding the questions asked
- To agree to participate in the research
- individuals diagnosed with hemorrhoidal disease
You may not qualify if:
- Those with existing proctologic disease other than hemorrhoidal disease and pelvic floor disease
- Patients with previous surgery for hemorrhoidal disease
- Patients with hemorrhoidal disease caused by portal hypertension
- Patients during pregnancy and diagnosed with postpartum hemorrhoidal disease
- those with benign prostatic hyperplasia or neurogenic bladder that may cause increased intra-abdominal pressure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Muğla Training and Research Hospital
Muğla, Menteşe, 48000, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 10, 2025
First Posted
March 14, 2025
Study Start
March 14, 2025
Primary Completion
September 14, 2025
Study Completion
October 14, 2025
Last Updated
May 11, 2025
Record last verified: 2025-03